Your browser doesn't support javascript.
loading
Palliation Strategy to Achieve Complete Repair in Symptomatic Neonates with Tetralogy of Fallot.
Law, Mark A; Glatz, Andrew C; Romano, Jennifer C; Chai, Paul J; Mascio, Christopher E; Petit, Christopher J; McCracken, Courtney E; Kelleman, Michael S; Nicholson, George T; Meadows, Jeffery J; Zampi, Jeffrey D; Shahanavaz, Shabana; Batlivala, Sarosh P; Pettus, Joelle; Pajk, Amy L; Hock, Kristal M; Goldstein, Bryan H; Qureshi, Athar M.
Afiliación
  • Law MA; Department of Pediatrics, University of Alabama at Birmingham, 1700 6th Ave S, Suite 9100, Birmingham, AL, 35233, USA. mlaw@uabmc.edu.
  • Glatz AC; Cardiac Center, Children's Hospital of Philadelphia, Perelman School of Medicine at the University of Pennsylvania, Philadelphia, PA, USA.
  • Romano JC; C.S. Mott Children's Hospital, University of Michigan, Ann Arbor, MI, Atlanta, USA.
  • Chai PJ; Children's Healthcare of Atlanta, Emory University School of Medicine, Atlanta, GA, USA.
  • Mascio CE; Cardiac Center, Children's Hospital of Philadelphia, Perelman School of Medicine at the University of Pennsylvania, Philadelphia, PA, USA.
  • Petit CJ; Columbia University Irving Medical Center, New York, NY, USA.
  • McCracken CE; Children's Healthcare of Atlanta, Emory University School of Medicine, Atlanta, GA, USA.
  • Kelleman MS; Children's Healthcare of Atlanta, Emory University School of Medicine, Atlanta, GA, USA.
  • Nicholson GT; Division of Cardiology, Monroe Carrell Jr. Children's Hospital, Vanderbilt University School of Medicine, Nashville, TN, USA.
  • Meadows JJ; Department of Pediatrics, University of California San Francisco, San Francisco, CA, USA.
  • Zampi JD; C.S. Mott Children's Hospital, University of Michigan, Ann Arbor, MI, Atlanta, USA.
  • Shahanavaz S; Department of Pediatrics, Heart Institute, Cincinnati Children's Hospital Medical Center, University of Cincinnati School of Medicine, Cincinnati, OH, USA.
  • Batlivala SP; Department of Pediatrics, Heart Institute, Cincinnati Children's Hospital Medical Center, University of Cincinnati School of Medicine, Cincinnati, OH, USA.
  • Pettus J; Children's Healthcare of Atlanta, Emory University School of Medicine, Atlanta, GA, USA.
  • Pajk AL; Department of Pediatrics, Heart Institute, Cincinnati Children's Hospital Medical Center, University of Cincinnati School of Medicine, Cincinnati, OH, USA.
  • Hock KM; Department of Pediatrics, University of Alabama at Birmingham, 1700 6th Ave S, Suite 9100, Birmingham, AL, 35233, USA.
  • Goldstein BH; Department of Pediatrics, Heart Institute, Cincinnati Children's Hospital Medical Center, University of Cincinnati School of Medicine, Cincinnati, OH, USA.
  • Qureshi AM; Department of Pediatrics, The Heart Institute, UPMC Children's Hospital of Pittsburgh, University of Pittsburg School of Medicine, Pittsburgh, PA, USA.
Pediatr Cardiol ; 43(7): 1587-1598, 2022 Oct.
Article en En | MEDLINE | ID: mdl-35381860
ABSTRACT
Neonates with symptomatic tetralogy of Fallot (sTOF) may undergo palliations with varying physiology, namely systemic to pulmonary artery connections (SPC) or right ventricular outflow tract interventions (RVOTI). A comparison of palliative strategies based on the physiology created is lacking. Consecutive sTOF neonates undergoing SPC or RVOTI from 2005-2017 were reviewed from the Congenital Cardiac Research Collaborative. The primary outcome was survival with successful complete repair (CR) by 18 months. A variety of secondary outcomes were assessed including overall survival, hospitalization-related comorbidities, and interstage reinterventions. Propensity score adjustment was utilized to compare treatment strategies. The cohort included 252 SPC (surgical shunt = 226, ductus arteriosus stent = 26) and 68 RVOTI (balloon pulmonary valvuloplasty = 48, RVOT stent = 11, RVOT patch = 9) patients. Genetic syndrome (29 [42.6%] v 75 [29.8%], p = 0.04), weight < 2.5 kg (28 [41.2%] v 68 [27.0%], p = 0.023), bilateral pulmonary artery Z-score < - 2 (19 [28.0%] v 36 [14.3%], p = 0.008), and pre-intervention antegrade flow (48 [70.6%] v 104 [41.3%], p < 0.001) were more common in RVOTI. Significant center differences were noted (p < 0.001). Adjusted survival to CR by 18 months (HR = 0.87, 95% CI = 0.63-1.21, p = 0.41) and overall survival (HR = 2.08, 95% CI = 0.93-4.65, p = 0.074) were similar. RVOTI had increased interstage reintervention (HR = 2.15, 95% CI = 1.36-3.99, p = 0.001). Total anesthesia (243 [213, 277] v 328 [308, 351] minutes, p < 0.001) and cardiopulmonary bypass times (117 [103, 132] v 151 [143, 160] minutes, p < 0.001) favored RVOTI. In this multicenter comparison of physiologic palliation strategies for sTOF, survival to successful CR and overall survival were similar; however, reintervention burden was significantly higher in RVOTI.
Asunto(s)
Palabras clave

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Asunto principal: Tetralogía de Fallot / Procedimiento de Blalock-Taussing Tipo de estudio: Diagnostic_studies / Observational_studies Límite: Humans / Infant / Newborn Idioma: En Revista: Pediatr Cardiol Año: 2022 Tipo del documento: Article País de afiliación: Estados Unidos

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Asunto principal: Tetralogía de Fallot / Procedimiento de Blalock-Taussing Tipo de estudio: Diagnostic_studies / Observational_studies Límite: Humans / Infant / Newborn Idioma: En Revista: Pediatr Cardiol Año: 2022 Tipo del documento: Article País de afiliación: Estados Unidos
...